ASAAP is a 48-month-long multicenter clinical trial research to evaluate the efficacy, safety, tolerability and pharmacokinetics of a new combination of antimalarial drugs, with particular focus on its successful application in one of the largest and most vulnerable demographics of Africa – children under five years of age.
ASAAP is coordinated by KCCR in Kumasi - Ghana, under the authority of the Kwame Nkrumah University of Science and Technology (KNUST) with 6 other countries (Gabon, Mali, Benin, Burkina Faso, Germany, and France). Both African and European partners are collaborating on equal terms to achieve maximum success from the planned activities.
Company Details
- Founded
- 2019
- Address
- South Asuogya, Kumasi, Kumasi,ashanti Region Pmb,ghana
- Industry
- Research Services
- NAICS
-
Scientific Research and Development ServicesResearch and Development in the Physical, Engineering, and Life SciencesResearch and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Website
- http://www.asaap-malaria.org
- HQ
- Kumasi, Ashanti Region
Asaap Malaria Project Questions
Asaap Malaria Project's website is http://www.asaap-malaria.org
Asaap Malaria Project's LinkedIn profile is https://gh.linkedin.com/company/asaap-malaria-project
Asaap Malaria Project's industry is
Research Services
Asaap Malaria Project's top competitors are
Asap,
Global Health And Infectious Diseases Group (Ghid-Kccr),
Silicon Labs,
Stop2030,
Ceri - Centre For Epidemic Response And Innovation,
Asapp,
Sedin Technologies,
Alois Solutions.
Asaap Malaria Project's categories are Research Services
Asaap Malaria Project's founding year is 2019
